In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

460 News Items found
A researcher pipettes in the lab
MSK Research Highlights, June 25, 2024

New MSK research helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to FDA approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach that shows promise in detecting lung cancer; found checkpoint inhibitors were effective against endometrial and ovarian cancers with DNA-repair deficiency; and shed new light on mTOR's role in metabolic enzyme degradation.
In the Lab
Illustration of cells with blue nuclei that have green DNA bits floating in the cytoplasm
Escape Artists: Cancer Cells Mimic Immune Cell Activity to Spread

Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.
In the Lab
Pictured: Cancer cell on blood vessel
Holding On and Hiding Out: How Cancer Cells Spread to the Brain and Thrive

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.
Dr. Jun Mao performs acupuncture
Acupuncture for Neuropathy, Cancer Pain, Anxiety, and More

Learn about the latest research on acupuncture from MSK and how our investigators are studying the benefits of acupuncture for relieving the side effects of cancer and its therapies.
Gail Goode
How MSK Is Increasing Diversity in Cancer Clinical Trials to Improve Treatments

An MSK clinical trial is helping Gail Goode overcome multiple myeloma and sheds new light on how cancer affects people of diverse ethnic backgrounds.
MSK exercise scientist Lee Jones, PhD, is seen in a gym.
Does Exercise Improve Survival After a Cancer Diagnosis? An Encouraging New Study

Learn how exercise can help many people live longer after they are diagnosed with cancer, according to a new study led by MSK exercise scientist Lee Jones, Chief of the Exercise-Oncology Service.
In the Clinic
Image of DNA helix with sequence in the background
Genetic ‘Scars’ Provide Clues for Tailoring Cancer Treatment

For the first time, scientists have determined the extent of DNA repair deficiencies across cancer types. Learn what it means for patients.
Finding
Vijai Joseph and Sabine Topka in the lab
Repairing DNA Damage in Cancer Cells

New findings could lead to a different kind of cancer drug that targets a DNA damage repair pathway called nucleotide excision repair.
Dr. Debyani Chakravarty
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.
Patient receiving stereotactic body radiation therapy at Memorial Sloan Kettering Cancer Center.
Ablative Radiotherapy Controls Resistant Non-Small Cell Lung Cancer in Clinical Trial

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.